Stroke Homing peptide (SHp)-guided deoxyribonuclease 1 (DNase1) and inhibition of myeloperoxidase (MPO) or peptidyl arginine deiminase-4 (PAD4) can reduce chemotherapy-induced mechanical hyperalgesia and prevent the development of CIPN in mice model [213]. Here, MPO is linked to stroke disorder.